Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacology down under in 2003.

Sheila A Doggrell1

  • 1Doggrell Biomedical Communications, Lynfield, Auckland, New Zealand. s_doggrell@ yahoo.com

Drug News & Perspectives
|April 21, 2004
PubMed
Summary

The Australasian Society for Clinical and Experimental Pharmacologists and Toxicologists meeting highlighted G-protein-coupled receptors, cellular repair, and cardiovascular protection. Novel drugs for GABA(C) receptors, cancer, inflammation, and pain were also discussed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consideration of the use of nalbuphine in idiopathic pulmonary fibrosis-associated cough: to cough or not to cough so much?

Expert opinion on investigational drugs·2026
Same author

Is supplemental vitamin D useful in the clinically isolated syndrome (CIS) typical of multiple sclerosis?

Expert opinion on pharmacotherapy·2026
Same author

Is seltorexant, an orexin-2 receptor antagonist, showing promise in insomnia?

Expert opinion on investigational drugs·2026
Same author

Does varenicline promote abstinence in youths who vape?

Expert opinion on pharmacotherapy·2025
Same author

Reply to: reframing guselkumab's benefit in ulcerative colitis: insights from QUASAR and emerging evidence.

Expert opinion on biological therapy·2025
Same author

With guselkumab, does the dual mechanisms to inhibit IL-23, help in ulcerative colitis?

Expert opinion on biological therapy·2025

Area of Science:

  • Pharmacology and Toxicology
  • Receptor Research
  • Drug Development

Background:

  • The Australasian Society for Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) annual meeting convened in Sydney, Australia.
  • The conference focused on key areas of pharmaceutical and toxicological research.

Framework:

  • Major focus on G-protein-coupled receptors (GPCRs).
  • Exploration of cellular and tissue growth and repair mechanisms.
  • Investigation of novel cardiovascular protective strategies.

Implementation:

  • Discussion of novel drugs targeting the GABA(C) receptor channel.
  • Consideration of anticancer prodrugs.
  • Review of anti-inflammatory agents and neuroprotective agents.
  • Examination of drugs used in pain therapeutics.

Implications:

  • Advancements in understanding GPCRs and their therapeutic potential.
  • Progress in developing drugs for cancer, inflammation, and pain management.
  • New insights into cardiovascular protection and tissue repair mechanisms.

Related Experiment Videos